Abstract
AbstractAvian influenza is an alarming disease, which has every possibility to evolve as human to human pandemic situation due to frequent mutation and genetic reassortment or recombination of Avian influenza(AI) virus. The greatest concern is that till date no satisfactory medicine or vaccines are available, leading to massive culling of poultry birds causing huge economic loss, and ban on export of chicken products, which emphasise the need develop alternative strategy for control of AI. In the current study we attempt to explore the molecular mechanism of innate immune potential of ducks against common viral diseases including Avian influenza. In the present study, we have characterized immune response molecules as duck TLR3, TLR7, and RIGI and predicted to have potent antiviral activities against different identified strains of Avian influenza through in silico studies (molecular docking). Future exploitation involve immunomodulation with the recombinant protein, transgenic or gene-edited chicken resistant to bird flu.
Publisher
Cold Spring Harbor Laboratory
Reference95 articles.
1. Pal A. , et al. Molecular characterization by Next generation sequencing and study of the Genetic basis of antiviral resistance of Indigenous ducks, in the National symposium on National Symposium on Biodynamic Animal Farming for the Management of Livestock Diversity under changing climatic scenario and 14 th Annual Convention of SOCDAB, 2017, CVAS, Mannuthy, Feb 8-10(2017).
2. WHO. https://www.who.int/biologicals/vaccines/influenza/en(2019).
3. Ying W , et al. Bat-derived influenza-like viruses H17N10 and H18N11. Trensa Microbiol; 183–91(2014).
4. New World bats harbour diverse influenza a viruses;PLoS pathog,2013
5. Continuing challenges in influenza